These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26668149)

  • 21. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.
    Abdalla TSA; Bolm L; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Bronsert P; Litkevych S; Honselmann KC; Braun R; Gebauer J; Hummel R; Keck T; Wellner UF; Deichmann S
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor.
    Huang XT; Xie JZ; Huang CS; Li JH; Chen W; Liang LJ; Yin XY
    HPB (Oxford); 2022 Dec; 24(12):2112-2118. PubMed ID: 36127226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
    Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
    Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).
    Yang G; Ji M; Chen J; Chen R; Chen Y; Fu D; Hou B; Huang H; Jiang L; Jin K; Ke N; Li Y; Li Y; Liang H; Liu A; Luo J; Ni Q; Shao C; Shen B; Sheng W; Song B; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Wang J; Wang J; Wang W; Wang W; Wu Z; Xu J; Yan Q; Yang N; Yang Y; Yin X; Yu X; Yuan C; Zeng S; Zhang G; Zhang R; Zhou Z; Zhu Z; Shao C
    Int J Oncol; 2017 Feb; 50(2):567-574. PubMed ID: 28035372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
    Ge W; Zhou D; Xu S; Wang W; Zheng S
    Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
    Regenet N; Carrere N; Boulanger G; de Calan L; Humeau M; Arnault V; Kraimps JL; Mathonnet M; Pessaux P; Donatini G; Venara A; Christou N; Bachelier P; Hamy A; Mirallié E
    Surgery; 2016 Mar; 159(3):901-7. PubMed ID: 26590096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
    Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
    Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
    Zhang N; He J; Maithel SK; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Lv Y; Zhang XF; Pawlik TM
    Ann Surg Oncol; 2024 May; 31(5):2882-2891. PubMed ID: 38097878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
    Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
    World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors.
    Genç CG; Jilesen AP; Partelli S; Falconi M; Muffatti F; van Kemenade FJ; van Eeden S; Verheij J; van Dieren S; van Eijck CHJ; Nieveen van Dijkum EJM
    Ann Surg; 2018 Jun; 267(6):1148-1154. PubMed ID: 28594340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort.
    Watley DC; Ly QP; Talmon G; Are C; Sasson AR
    Am J Surg; 2015 Dec; 210(6):1192-5; discussion 1195-6. PubMed ID: 26674063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative prediction of lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors from clinical and MRI features: a multicenter study.
    Zhu HB; Nie P; Jiang L; Hu J; Zhang XY; Li XT; Lu M; Sun YS
    Insights Imaging; 2022 Oct; 13(1):162. PubMed ID: 36209332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival.
    Toste PA; Kadera BE; Tatishchev SF; Dawson DW; Clerkin BM; Muthusamy R; Watson R; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Gastrointest Surg; 2013 Dec; 17(12):2105-13. PubMed ID: 24101447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
    Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical strategies for non-functioning pancreatic neuroendocrine tumours.
    Kim MJ; Choi DW; Choi SH; Heo JS; Park HJ; Choi KK; Jang KT; Sung JY
    Br J Surg; 2012 Nov; 99(11):1562-8. PubMed ID: 23027073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
    Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.